Most published studies show decreased irisin concentrations in patients with T2DM regardless of the time of diagnosis and whether they are undergoing any treatment [26–28] and even lower concentration in the presence of complications of T2DM [29, 30]. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.